glp-1 ra drugs list What to Make of the Coverage and Cost Landscape GLP-1 Medications Infographic | Medidex

Injectable GLP-1s like Wegovy or Zepbound are reviewed on a case-by-case, non-formulary basis

Wanner C, Inzucchi SE, Lachin JM et al

We believe that medical supervision is the key to managing the nuances of GLP-1 therapy safely

Our analysis included data from 69 individuals and revealed a significant deterioration in glycemic control following the discontinuation

Public Plan Spending Context The Globe and Mail reports that public plans spent $794 million on Ozempic in 2024, and if plans cover Mounjaro, it could cost them an estimated $1.97 billion over three years, about $820 million more than the plans currently spend on comparable drugs over a similar period [Source: theglobeandmail.com/business/economy/article-canada-drug-agency-mounjaro-recommendation-type-2-diabetes/]

In animal experiments, particularly in mouse models, GDF-15 enhances satiety and reduces food intake through its action on the central nervous system